Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Mahner

Showing results (391-400 of 455) with videos related to

Pageof 46
Sort By:
Gynecologic Oncology|February 15, 2019
Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 studyStephan Polterauer, Richard Schwameis, Christoph Grimm, et al.
Gynecologic Oncology|June 23, 2019
Predictive factors for lymph node metastases in vulvar cancer. An analysis of the AGO-CaRE-1 multicenter studyRüdiger Klapdor, Linn Wölber, Lars Hanker, et al.
Iscience|December 16, 2025
Organoid platinum-resistance model identifies KRT17 as a biomarker of targeted therapy in ovarian cancerJuliane Reichenbach, Juliana Schmid, Sophia Hierlmayer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 21, 2016
Pertuzumab Plus Chemotherapy for Platinum-Resistant Ovarian Cancer: Safety Run-in Results of the PENELOPE TrialAntonio González-Martín, Patricia Pautier, Sven Mahner, et al.
International Journal of Surgery (London, England)|February 24, 2025
Risk factors for anastomotic leakage and its impact on survival outcomes in radical multivisceral surgery for advanced ovarian cancer: an AGO-OVAR.OP3/LION exploratory analysisFabian Trillsch, Bastian Czogalla, Sven Mahner, et al.
Annals of Surgical Oncology|March 16, 2021
Role of Pelvic Lymph Node Resection in Vulvar Squamous Cell Cancer: A Subset Analysis of the AGO-CaRE-1 StudyLinn Woelber, Mareike Bommert, Philipp Harter, et al.
European Radiology|August 29, 2024
Preserved prenatal lung growth assessed by fetal MRI in the omicron-dominated phase of the SARS-CoV-2 pandemicGloria Biechele, Vanessa Koliogiannis, Philippe Rennollet, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 5, 2023
Interviews conducted at the European Society of Gynaecological Oncology 2022 Congress: a ENYGO-IJGC Fellows initiativeMartina Aida Angeles, Felix Boria, Alexander B Shushkevich, et al.
Gynecologic Oncology|November 19, 2021
Adjuvant radiotherapy and local recurrence in vulvar cancer - a subset analysis of the AGO-CaRE-1 studyLinn Woelber, Katharina Prieske, Christine Zu Eulenburg, et al.
Computational and Structural Biotechnology Journal|May 4, 2019
Interrelations of Sphingolipid and Lysophosphatidate Signaling with Immune System in Ovarian CancerAnastasia Meshcheryakova, Martin Svoboda, Markus Jaritz, et al.
Pageof 46

Showing results (391-400 of 455) with videos related to

Sort By:
Pageof 46
Gynecologic Oncology|February 15, 2019
Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 studyStephan Polterauer, Richard Schwameis, Christoph Grimm, et al.
Gynecologic Oncology|June 23, 2019
Predictive factors for lymph node metastases in vulvar cancer. An analysis of the AGO-CaRE-1 multicenter studyRüdiger Klapdor, Linn Wölber, Lars Hanker, et al.
Iscience|December 16, 2025
Organoid platinum-resistance model identifies KRT17 as a biomarker of targeted therapy in ovarian cancerJuliane Reichenbach, Juliana Schmid, Sophia Hierlmayer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 21, 2016
Pertuzumab Plus Chemotherapy for Platinum-Resistant Ovarian Cancer: Safety Run-in Results of the PENELOPE TrialAntonio González-Martín, Patricia Pautier, Sven Mahner, et al.
International Journal of Surgery (London, England)|February 24, 2025
Risk factors for anastomotic leakage and its impact on survival outcomes in radical multivisceral surgery for advanced ovarian cancer: an AGO-OVAR.OP3/LION exploratory analysisFabian Trillsch, Bastian Czogalla, Sven Mahner, et al.
Annals of Surgical Oncology|March 16, 2021
Role of Pelvic Lymph Node Resection in Vulvar Squamous Cell Cancer: A Subset Analysis of the AGO-CaRE-1 StudyLinn Woelber, Mareike Bommert, Philipp Harter, et al.
European Radiology|August 29, 2024
Preserved prenatal lung growth assessed by fetal MRI in the omicron-dominated phase of the SARS-CoV-2 pandemicGloria Biechele, Vanessa Koliogiannis, Philippe Rennollet, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 5, 2023
Interviews conducted at the European Society of Gynaecological Oncology 2022 Congress: a ENYGO-IJGC Fellows initiativeMartina Aida Angeles, Felix Boria, Alexander B Shushkevich, et al.
Gynecologic Oncology|November 19, 2021
Adjuvant radiotherapy and local recurrence in vulvar cancer - a subset analysis of the AGO-CaRE-1 studyLinn Woelber, Katharina Prieske, Christine Zu Eulenburg, et al.
Computational and Structural Biotechnology Journal|May 4, 2019
Interrelations of Sphingolipid and Lysophosphatidate Signaling with Immune System in Ovarian CancerAnastasia Meshcheryakova, Martin Svoboda, Markus Jaritz, et al.
Pageof 46